new warnings concerning Champix and an increased risk of cardiac events in patients with heart disease

Please see updated FDA safety information regarding the risk of cardiovascular events with Chantix (varenicline).

People will worry about new warnings concerning Champix and an increased risk of cardiac events in patients with heart disease.

Some researchers say there MIGHT be a higher risk...but this is controversial.

Any cardiac risk is likely to be small...if it exists at all.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote